These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20362738)

  • 41. Risperidone and Parkinson's disease.
    Factor SA; Molho ES; Friedman JH
    Mov Disord; 2002 Jan; 17(1):221-2. PubMed ID: 11835472
    [No Abstract]   [Full Text] [Related]  

  • 42. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.
    Menza MM; Palermo B; Mark M
    Ann Clin Psychiatry; 1999 Sep; 11(3):141-4. PubMed ID: 10482124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A report of successful treatment of psychosis in epilepsy with risperidone.
    Mahgoub NA
    J Neuropsychiatry Clin Neurosci; 2007; 19(3):347-8. PubMed ID: 17827431
    [No Abstract]   [Full Text] [Related]  

  • 44. Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.
    Aarsland D; Larsen JP; Lim NG; Tandberg E
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):392-4. PubMed ID: 10440017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ziprasidone in the treatment of Parkinson's disease psychosis.
    Shiah IS; Lin CL; Mao WC; Luu SU
    Eur Psychiatry; 2006 Dec; 21(8):578-9. PubMed ID: 16139485
    [No Abstract]   [Full Text] [Related]  

  • 46. Risperidone: a once-daily dosage schedule.
    Gupta S; Gilroy WR
    Ann Clin Psychiatry; 1995 Dec; 7(4):211. PubMed ID: 8721896
    [No Abstract]   [Full Text] [Related]  

  • 47. Psychopharmacology news.
    Silva R
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):91. PubMed ID: 19232027
    [No Abstract]   [Full Text] [Related]  

  • 48. Psychosis in Parkinson's disease: therapeutic options.
    Hasnain M
    Drugs Today (Barc); 2011 May; 47(5):353-67. PubMed ID: 22013566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder.
    Citrome L; Krakowski M; Greenberg WM; Andrade E; Volavka J
    J Clin Psychiatry; 2001 Nov; 62(11):901. PubMed ID: 11775051
    [No Abstract]   [Full Text] [Related]  

  • 50. The management of psychosis in movement disorder patients.
    Chou KL; Borek LL; Friedman JH
    Expert Opin Pharmacother; 2007 May; 8(7):935-43. PubMed ID: 17472539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hallucinations and the spectrum of psychosis in Parkinson's disease.
    Frei K; Truong DD
    J Neurol Sci; 2017 Mar; 374():56-62. PubMed ID: 28108020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quetiapine in the elderly with parkinsonism and psychosis.
    Wijnen HH; van der Heijden FM; van Schendel FM; Tuinier S; Verhoeven WM
    Eur Psychiatry; 2003 Nov; 18(7):372-3. PubMed ID: 14643568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of risperidone on prolactinoma growth in a psychotic woman.
    Pal JK; Sarino WA
    Psychosom Med; 2000; 62(5):736-8. PubMed ID: 11020104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quetiapine in postpartum psychosis.
    Gobbi G
    J Clin Psychopharmacol; 2014 Dec; 34(6):744-5. PubMed ID: 24943395
    [No Abstract]   [Full Text] [Related]  

  • 55. False-positive methadone drug screens during quetiapine treatment.
    Fischer M; Reif A; Polak T; Pfuhlmann B; Fallgatter AJ
    J Clin Psychiatry; 2010 Dec; 71(12):1696. PubMed ID: 21190642
    [No Abstract]   [Full Text] [Related]  

  • 56. [Modern approaches to treatment of psychosis in Parkinson's disease].
    Cozac VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):103-109. PubMed ID: 28635863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Another cause of 'pseudophaeochromocytoma'--quetiapine associated with a false positive normetanephrine result.
    Doogue M; Soule S; Hunt P
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):472-3. PubMed ID: 17645566
    [No Abstract]   [Full Text] [Related]  

  • 58. Risperidone in Parkinson's disease.
    Ford B; Lynch T; Greene P
    Lancet; 1994 Sep; 344(8923):681. PubMed ID: 7520964
    [No Abstract]   [Full Text] [Related]  

  • 59. "Awakenings" effect with risperidone.
    Stip E; Tourjman V; Lew V; Fabian J; Cormier H; Landry P; Lalonde P; Cournoyer J
    Am J Psychiatry; 1995 Dec; 152(12):1833. PubMed ID: 8526260
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful treatment of tuberous sclerosis with psychosis and obsessive-compulsive disorder: A case report.
    Rao SA; Rao MG; Rao NP; Varambally S; Gangadhar BN
    Psychiatry Clin Neurosci; 2015 Aug; 69(8):504-5. PubMed ID: 25907259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.